The Israeli Ministry of Health Elects Kamada Ltd. to be the Exclusive Developer and Manufacturer of Snakebite Antiserums in Israel
WEIZMANN SCIENCE PARK, NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada (Tel-Aviv:KMDA), a biopharmaceutical company (the “Company”), (www.kamada.com) engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that the Israeli Ministry of Health elected Kamada to be the exclusive developer and manufacturer of snakebite antiserums in Israel.